Skip to content

Clinical trials

Phase 2 Pancreatic Neoplasms trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pancreatic Neoplasms Phase: Phase 2 Country / region: China Clear all

125 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20081
20102
20134
20142
20155
20164
20173
20183
201910
20206
20215
20228
202314
202425
202520
202612

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting42
Unknown status41
Completed17
Not yet recruiting17
Active, not recruiting5
Terminated2
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fudan University18
Tianjin Medical University Cancer Institute and Hospital9
Zhejiang University7
Ruijin Hospital6
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School6
Changhai Hospital5
Shandong Cancer Hospital and Institute4
Shanghai Zhongshan Hospital4
Sun Yat-sen University4
Second Affiliated Hospital, Zhejiang University, School of Medicine3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pancreatic Neoplasms125
Colorectal Neoplasms7
Breast Neoplasms5
Stomach Neoplasms4
Biliary Tract Neoplasms3
Carcinoma, Non-Small-Cell Lung3
Lung Neoplasms3
Melanoma3
Neoplasm Metastasis3
Ovarian Neoplasms3

Trials

Showing 1 to 25 of 125. Each trial links to its page on Pharma Observatory.

25 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.